Lejeune, M.; Reverté, L.; Gallardo, N.; Sauras, E.; Bosch, R.; Mata, D.; Roso, A.; Petit, A.; Peg, V.; Riu, F.;
et al. Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients. Int. J. Mol. Sci. 2023, 24, 11297.
https://doi.org/10.3390/ijms241411297
AMA Style
Lejeune M, Reverté L, Gallardo N, Sauras E, Bosch R, Mata D, Roso A, Petit A, Peg V, Riu F,
et al. Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients. International Journal of Molecular Sciences. 2023; 24(14):11297.
https://doi.org/10.3390/ijms241411297
Chicago/Turabian Style
Lejeune, Marylène, Laia Reverté, Noèlia Gallardo, Esther Sauras, Ramon Bosch, Daniel Mata, Albert Roso, Anna Petit, Vicente Peg, Francisco Riu,
and et al. 2023. "Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients" International Journal of Molecular Sciences 24, no. 14: 11297.
https://doi.org/10.3390/ijms241411297
APA Style
Lejeune, M., Reverté, L., Gallardo, N., Sauras, E., Bosch, R., Mata, D., Roso, A., Petit, A., Peg, V., Riu, F., García-Fontgivell, J., Relea, F., Vieites, B., de la Cruz-Merino, L., Arenas, M., Rodriguez, V., Galera, J., Korzynska, A., Plancoulaine, B.,
... López, C.
(2023). Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients. International Journal of Molecular Sciences, 24(14), 11297.
https://doi.org/10.3390/ijms241411297
